SPONSOR
Usynova Pharmaceuticals Ltd.
Total Trials
2
Recruiting
2
Phases
Phase 1
Usynova Pharmaceuticals Ltd. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Plaque Psoriasis, Healthy Volunteer, Moderate to Severe Plaque Psoriasis.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Usynova Pharmaceuticals Ltd.
How many clinical trials has Usynova Pharmaceuticals Ltd. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Usynova Pharmaceuticals Ltd., of which 2 are actively recruiting participants. These trials cover conditions including Plaque Psoriasis, Healthy Volunteer, Moderate to Severe Plaque Psoriasis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Usynova Pharmaceuticals Ltd. research focus on?
Usynova Pharmaceuticals Ltd. clinical trials span Plaque Psoriasis, Healthy Volunteer, Moderate to Severe Plaque Psoriasis. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Usynova Pharmaceuticals Ltd. clinical trial?
To participate in a Usynova Pharmaceuticals Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Usynova Pharmaceuticals Ltd. trials with current recruitment status updated daily.
Clinical Trials by Usynova Pharmaceuticals Ltd.
NCT07038720 Phase 1
Recruiting
A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis
Plaque Psoriasis
NCT07234591
Recruiting
A Study to Evaluate Effectiveness and Safety of a TYK2 Inhibitor in Subjects With Moderate to Severe Plaque Psoriasis
Plaque Psoriasis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology